{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:26:14Z","timestamp":1760549174990,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.ijpharm.2011.10.026","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T13:18:49Z","timestamp":1318943929000},"page":"52-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay"],"prefix":"10.1016","volume":"422","author":[{"given":"Sarah Maud","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen Timothy","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Kirchmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Fricker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2011.10.026_bib0005","doi-asserted-by":"crossref","first-page":"7936","DOI":"10.1021\/bi960497i","article-title":"Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes","volume":"35","author":"Albalak","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0010","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/jps.20553","article-title":"Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir","volume":"95","author":"Brouwers","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-4622(01)00126-0","article-title":"Partition coefficients of beta-blockers in bile salt\/lecithin micelles as a tool to assess the role of mixed micelles in gastrointestinal absorption","volume":"90","author":"de Castro","year":"2001","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0020","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/j.2042-7158.2011.01301.x","article-title":"In-vitro permeability of poorly water soluble drugs in the phospholipid vesicle-based permeation assay: the influence of nonionic surfactants","volume":"63","author":"Fischer","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0030","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2005.08.007","article-title":"Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion","volume":"27","author":"Flaten","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0025","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejps.2006.03.008","article-title":"Drug permeability across a phospholipid vesicle-based barrier: 2. Characterization of barrier structure, storage stability and stability towards pH changes","volume":"28","author":"Flaten","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2008.04.001","article-title":"Drug permeability across a phospholipid vesicle-based barrier: 4. The effect of tensides, co-solvents and pH changes on barrier integrity and on drug permeability","volume":"34","author":"Flaten","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0040","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejps.2006.11.017","article-title":"Drug permeability across a phospholipid vesicle based barrier: 3. Characterization of drug-membrane interactions and the effect of agitation on the barrier integrity and on the permeability","volume":"30","author":"Flaten","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0045","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2008.04.034","article-title":"Use of simulated intestinal fluid for Caco-2 permeability assay of lipophilic drugs","volume":"360","author":"Fossati","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0050","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0055","doi-asserted-by":"crossref","first-page":"E63","DOI":"10.1208\/pt040463","article-title":"Quantification of various phosphatidylcholines in liposomes by enzymatic assay","volume":"4","author":"Grohganz","year":"2003","journal-title":"AAPS PharmSciTech"},{"year":"1990","series-title":"Comprehensive Medicinal Chemistry: the Rational Design, Mechanistic Study & Therapeutic Application of Chemical Compounds","author":"Hansch","key":"10.1016\/j.ijpharm.2011.10.026_bib0060"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0065","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/nprot.2007.303","article-title":"Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers","volume":"2","author":"Hubatsch","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.01.014","article-title":"Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers","volume":"274","author":"Ingels","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-5173(01)00897-3","article-title":"Simulated intestinal fluid as transport medium in the Caco-2 cell culture model","volume":"232","author":"Ingels","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0080","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0085","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/j.2042-7158.2010.01172.x","article-title":"In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier","volume":"62","author":"Kanzer","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0090","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1023\/A:1026107906191","article-title":"In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs","volume":"20","author":"Kataoka","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0095","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1248\/cpb.20.1656","article-title":"Effect of bile salts on the gastrointestinal absorption of drugs. IV. Site of intestinal absorption of sodium taurocholate and its consequence on drug absorption in the rat","volume":"20","author":"Kimura","year":"1972","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0100","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0005-2760(96)00126-9","article-title":"Interaction of liposomes with human skin in vitro\u2014the influence of lipid composition and structure","volume":"1304","author":"Kirjavainen","year":"1996","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0105","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/jps.22122","article-title":"Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity","volume":"99","author":"Kleberg","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0110","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1111\/j.2042-7158.2010.01023.x","article-title":"Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies","volume":"62","author":"Kleberg","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5173(01)00698-6","article-title":"Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2","volume":"222","author":"Krishna","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0120","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s11095-008-9556-9","article-title":"Optimisation of the caco-2 permeability assay using experimental design methodology","volume":"25","author":"Lakeram","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0125","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejpb.2011.02.007","article-title":"Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs","volume":"78","author":"Lehto","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejps.2007.08.002","article-title":"Development of simulated intestinal fluids containing nutrients as transport media in the Caco-2 cell culture model: assessment of cell viability, monolayer integrity and transport of a poorly aqueous soluble drug and a substrate of efflux mechanisms","volume":"32","author":"Lind","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0005-2736(88)90019-3","article-title":"Interaction of the fluorescent probe N-(lissamine Rhodamine B sulfonyl)dipalmitoylphosphatidylethanolamine with phosphatidylcholine bilayers","volume":"940","author":"Massari","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0140","doi-asserted-by":"crossref","DOI":"10.1021\/mp200181v","article-title":"The solubility\u2013permeability interplay: mechanistic modeling and predictive application of the impact of micellar solubilization on intestinal permeation","author":"Miller","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0145","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1016062224568","article-title":"Estimation of the increase in solubility of drugs as a function of bile salt concentration","volume":"13","author":"Mithani","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0150","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1021\/bi00364a021","article-title":"Low concentrations of bile salts increase the rate of spontaneous phospholipid transfer between vesicles","volume":"25","author":"Nichols","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0378-5173(01)00701-3","article-title":"The effect of alpha-tocopherol on the in vitro solubilisation of lipophilic drugs","volume":"222","author":"Nielsen","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/03639040500465991","article-title":"Use of simulated intestinal fluids with Caco-2 cells and rat ileum","volume":"32","author":"Patel","year":"2006","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0165","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s11095-005-8192-x","article-title":"The effects of food on the dissolution of poorly soluble drugs in human and in model small intestinal fluids","volume":"22","author":"Persson","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0170","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1021\/bi00366a042","article-title":"Structural changes in membranes of large unilamellar vesicles after binding of sodium cholate","volume":"25","author":"Schubert","year":"1986","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0175","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000198984","article-title":"Studies on the mechanism of bile salt-induced liposomal membrane damage","volume":"28","author":"Schubert","year":"1983","journal-title":"Digestion"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0180","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1021\/bi00424a015","article-title":"Structural changes in vesicle membranes and mixed micelles of various lipid compositions after binding of different bile salts","volume":"27","author":"Schubert","year":"1988","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0185","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/10837451003664099","article-title":"The apparent solubilizing capacity of simulated intestinal fluids for poorly water-soluble drugs","volume":"16","author":"Schwebel","year":"2011","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/mp800148u","article-title":"Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers","volume":"6","author":"Sheng","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0195","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1002\/jps.21305","article-title":"Simulation modelling of human intestinal absorption using Caco-2 permeability and kinetic solubility data for early drug discovery","volume":"97","author":"Thomas","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2011.10.026_bib0200","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0928-0987(00)00076-2","article-title":"Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells","volume":"10","author":"Yamashita","year":"2000","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311009653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517311009653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:27:47Z","timestamp":1759915667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517311009653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":40,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0378517311009653"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.10.026","relation":{},"ISSN":["0378-5173"],"issn-type":[{"type":"print","value":"0378-5173"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2011.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}